Tomas FM, Lemmey AB, Read LC, Ballard FJ
[DOI] [PubMed] [Google Scholar] 4.Wiznitzer M
Your doctor should conduct regular monitoring during Zepbound treatment, including weight and vital signs at each visit, periodic assessment of obesity-related conditions, monitoring for adverse effects (including potential pancreatitis, gallbladder disease, dehydration, or allergic reactions), and laboratory testing as indicated (such as hemoglobin A1c if you have diabetes)
The US Food and Drug Administration (FDA) has approved six drugs for long-term, chronic weight management [5]
GLP-1s are available as daily or weekly injections, though daily oral versions are available
Such delivery systems include transdermal, nasal, buccal, sublingual and injectable dosage forms